Skip to main content
. 2022 May 4;20(5):e07290. doi: 10.2903/j.efsa.2022.7290

Spread of the disease

NUTS 3 areas with at least one ASF notification during the reporting period

  • Click on the LINK to see the spread of the disease since the first confirmation

  • % of the NUTS 3 areas in the country had at least one case or outbreak of ASF reported in the reporting period

Surveillance (samples tested for ASF) in whole country during reporting period Passive surveillance in WB* Passive surveillance in DP*
Diagnostic test(s) used Total samples Positive samples Diagnostic test(s) used Total samples Positive samples
PCR 65 20 PCR 3,959 3
ELISA 6 1 ELISA 158 0
ELISA + IPT 1 1 ELISA + IPT 0 NA
ELISA + IB 0 NA ELISA + IB 0 NA
Active surveillance in WB* Active surveillance in DP*
Diagnostic test(s) used Total samples Positive samples Diagnostic test(s) used Total samples Positive samples
PCR 10,081 12 PCR 1,011 0
ELISA 10,069 75 ELISA 61 0
ELISA + IPT 75 64 ELISA + IPT 0 NA
ELISA + IB 0 NA ELISA + IB 0 NA
Surveillance (samples tested for ASF) in NUTS 3 areas with at least one ASF notification during the reporting period Passive surveillance in WB* Passive surveillance in DP*
Diagnostic test(s) used Total samples Positive samples Diagnostic test(s) used Total samples Positive samples
PCR 28 20 PCR 1,213 3
ELISA 2 1 ELISA 14 0
ELISA + IPT 1 1 ELISA + IPT 0 NA
ELISA + IB 0 NA ELISA + IB 0 NA
Active surveillance in WB* Active surveillance in DP*
Diagnostic test(s) used Total samples Positive samples Diagnostic test(s) used Total samples Positive samples
PCR 1,975 12 PCR ND ND
ELISA 1,976 27 ELISA ND ND
ELISA + IPT 27 23 ELISA + IPT ND ND
ELISA + IB 0 NA ELISA + IB ND ND

ND: no data provided to EFSA; NA: Not applicable.

*: See Section 3.1.1 for definitions.